STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology STROBE-ME: An extension of the STROBE statement

Journal of Clinical Epidemiology

Volumn 64, Issue 12, 2011, Pages 1350-1363

  Gallo, Valentina ^a,b   Egger, Matthias ^c   McCormack, Valerie ^d   Farmer, Peter B ^e   Ioannidis, John P A ^f,g   Kirsch Volders, Micheline ^h   Matullo, Giuseppe ^i,j   Phillips, David H ^k   Schoket, Bernadette ^l   Stromberg, Ulf ^m   Vermeulen, Roel ⁿ   Wild, Christopher ^d   Porta, Miquel ^o   Vineis, Paolo ^a,i  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF IOANNINA   (Greece)

^h VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

ⁱ Human Genetics Foundation   (Italy)

^j UNIVERSITY OF TURIN   (Italy)

^k INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^l NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^m LUND UNIVERSITY   (Sweden)

ⁿ UTRECHT UNIVERSITY   (Netherlands)

^o UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BODY COMPOSITION; CASE CONTROL STUDY; CASE REPORT; CENTRIFUGATION; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; HUMAN; INFORMED CONSENT; LABORATORY TEST; LIMIT OF DETECTION; MEDICAL ETHICS; MEDICAL RESEARCH; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; SHELF LIFE; SOLUBILITY; STORAGE; STRENGTHENING REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY; THAWING; VALIDITY; VOLUNTARY REPORTING;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; MOLECULAR EPIDEMIOLOGY; OBSERVATION; PRACTICE GUIDELINES AS TOPIC; PUBLISHING; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 80055020569     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2011.07.010     Document Type: Article

References (53)

1. C. Wild, P. Vineis, and S. Garte Molecular epidemiology of chronic diseases 2008 Wiley
2. P. Vineis Individual susceptibility to carcinogens Oncogene 23 2004 6477 6483
3. S. Bonassi, and W.W. Au Biomarkers in molecular epidemiology studies for health risk prediction Mutat Res 511 2002 73 86
4. R. Milikan The changing face of epidemiology in the genomics era Epidemiology 13 2002 472 480
5. D.J. Hunter The future of molecular epidemiology Int J Epidemiol 28 1999 S1012 S1014
6. A.G. Rundle, P. Vineis, and H. Ahsan Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev 14 2005 1899 1907
7. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 97 2005 1180 1184
8. P.A. Kyzas, D. Denaxa-Kyza, and J.P. Ioannidis Almost all articles on cancer prognostic markers report statistically significant results Eur J Cancer 43 2007 2559 2579
9. A. Blair, R. Saracci, P. Vineis, P. Cocco, F. Forastiere, P. Grandjean, M. Kogevinas, D. Kriebel, A. McMichael, N. Pearce, M. Porta, J. Samet, D.P. Sandler, A.S. Costantini, and H. Vainio Epidemiology, public health and the rhetoric of false positives Environ Health Perspect 117 2009 1809 1813
10. P.A. Kyzas, K.T. Loizou, and J.P. Ioannidis Selective reporting biases in cancer prognostic factor studies J Natl Cancer Inst 97 14 2005 1043 1055
11. J.P.A. Ioannidis, and O. Panagiotou Comparison of effect sizes of biomarkers reported in highly-cited articles versus subsequent meta-analyses JAMA 305 2011 2200 2210
12. B. Lumbreras, L.A. Parker, M. Porta, M. Pollan, J.P. Ioannidis, and I. Hernandez-Aguado Overinterpretation of clinical applicability in molecular diagnostic research Clin Chem 55 2009 786 794
13. Ioannidis JP, Tarone R, McLaughlin JK. The False-positive to False-negative Ratio in Epidemiologic Studies. Epidemiology. 2011, in press.
14. K.F. Schulz, D.G. Altman, D. Moher CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials PLoS Med 7 3 2010 e1000251
15. P.F. Whiting, M.E. Weswood, A.W. Rutjes, J.B. Reitsma, P.N. Bossuyt, and J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
16. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, and J.P. Vandenbroucke The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies PLoS Med 4 2007 e296
17. J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, and M. Egger STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration PLoS Med 4 10 2007 Oct 16 e297 Review
18. A.E. Fung, R. Palanki, S.J. Bakri, E. Depperschmidt, and A. Gibson Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies Ophthalmology 116 2009 286 296
19. B. Da Costa, M. Cevallos, D. Altman, A.W. Rutjes, and M. Egger Uses and misuses of the STROBE statement: bibliographic study BMJ 2010 doi: 10.1136/bmjopen-2010-000048. Open
20. J. Little, J.P. Higgins, J.P. Ioannidis, D. Moher, F. Gagnon, E. von Elm, M.J. Khoury, B. Cohen, G. Davey-Smith, J. Grimshaw, P. Scheet, M. Gwinn, R.E. Williamson, G.Y. Zou, K. Hutchings, C.Y. Johnson, V. Tait, M. Wiens, J. Golding, C. van Duijn, J. McLaughlin, A. Paterson, G. Wells, I. Fortier, M. Freedman, M. Zecevic, R. King, C. Infante-Rivard, A.F. Stewart, and N. Birkett Strengthening the reporting of genetic association studies (STREGA)-an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement J Clin Epidemiol 62 2009 597-608.e4
21. L. Casteleyn, B. Dumez, A. Jamers, and K. Van Damme Ethics and data protection in human biomarker studies 2010 ECNIS Publications Lodz
22. D.A. Haines, T.E. Arbuckle, E. Lye, M. Legrand, M. Fisher, R. Langlois, and W. Fraser Reporting results of human biomonitoring of environmental chemicals to study participants: a comparison of approaches followed in two Canadian studies J Epidemiol Community Health 65 2011 191 198
23. D.F. Ransohoff Rules of evidence for cancer molecular-marker discovery and validation Nat Rev Cancer 4 2004 309 314
24. M. Porta A dictionary of epidemiology 5th. edition 2008 Oxford University Press New York 21 69, 129-130, 152, 157-158
25. M. Porta, J. Pumarega, T. López, M. Jariod, E. Marco, and J.O. Grimalt Influence of tumor stage, symptoms and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer Cancer Causes Control 20 2009 1893 1906
26. M. Porta, J. Pumarega, O. Ferrer-Armengou, T. López, J. Alguacil, and N. Malats Timing of blood extraction in epidemiologic and proteomic studies. Results and proposals from the PANKRAS II Study Eur J Epidemiol 22 2007 577 588
27. M. Ruchirawa, C. Mahidol, C. Tangjarukij, S. Pui-ock, O. Jensen, O. Kampeerawipakorn, J. Tuntaviroon, A. Aramphongphan, and H. Autrup Exposure to genotoxins present in ambient air in Bangkok, Thailand - particle associated polycyclic aromatic hydrocarbons and biomarkers Sci Total Environ 287 2002 121 132
28. M. Sorensen, H. Autrup, O. Hertel, H. Wallin, L.E. Knudsen, and S. Loft Personal exposure to PM2.5 and biomarkers of DNA damage Cancer Epidemiol Biomarkers Prev 12 2003 191 196
29. M. Dusinska, B. Vallova, M. Ursinyova, V. Hladikova, B. Smolkova, L. Wsolova, K. Raslova, and A.R. Collins DNA damage and antioxidants; fluctuations through the year in a central European population group Food Chem Toxicol 40 2002 1119 1123
30. L. Giovannelli, C. Saieva, G. Masala, G. Testa, S. Salvini, V. Pitozzi, E. Riboli, P. Dolara, and D. Palli Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population Carcinogenesis 23 2002 1483 1489
31. P. Moller, H. Wallin, E. Holst, and L.E. Knudsen Sunlight-induced DNA damage in human mononuclear cells FASEB Journal 16 2002 45 53
32. J.P.A. Ioannidis Genetic and molecular epidemiology J Epidemiol Community Health 61 2007 757 758
33. D.H. Phillips, and M. Castegnaro Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols Mutagenesis 14 1999 301 315
34. J.T. Leek, R.B. Scharpf, H.C. Bravo, D. Simcha, B. Langmead, W.E. Johnson, D. Geman, K. Baggerly, and R.A. Irizarry Tackling the widespread and critical impact of batch effects in high-throughput data Nat Rev Genet 11 10 2010 733 739
35. P.J. Castaldi, I.J. Dahabreh, and J.P. Ioannidis An empirical assessment of validation practices for molecular classifiers Brief Bioinform 12 3 2011 May 189 202 Epub 2011 Feb 7
36. D.G. Altman, and P. Royston What do we mean by validating a prognostic model? Stat Med 19 4 2000 Feb 29 453 473
37. N.E. Caporaso Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol Biomarkers Prev 11 2002 1544 1549
38. H. Vainio Genetic biomarkers and occupational epidemiology -recollections, reflections and reconsiderations Scand J Work Environ Health 30 2004 1 3
39. D. Moher, K.F. Schulz, I. Simera, and D.G. Altman Guidance for developers of health research reporting guidelines 2010 PLoS Med 7 2 2010 e1000217
40. I. Simera, D.G. Altman, D. Moher, K.F. Schulz, and J. Hoey Guidelines for reporting health research: the EQUATOR network's survey of guideline authors PLoS Med 5 6 2008 e139
41. I. Simera, D. Moher, J. Hoey, K.F. Schulz, and D.G. Altman A catalogue of reporting guidelines for health research Eur J Clin Invest 40 1 2010 35 53
42. P. Vineis, and F. Perera Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old Cancer Epidemiol Biomarkers Prev 16 2007 1954 1965
43. A.J. Atkinson, W.A. Colburn, V.G. DeGruttola, D.L. DeMets, G.J. Downing, D.F. Hoth, J.A. Oates, C.C. Peck, R.T. Schooley, B.A. Spilker, J. Woodcock, S.L. Zeger Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89 95
44. I. Decordier, K. VandeLoock, and M. Kirsch-Volders Phenotyping for DNA repair capacity Mutat Res 705 2 2010 107 129
45. J.P. Ioannidis, and I. Tzoulaki What makes a good predictor? the evidence applied to coronary artery calcium score JAMA 303 16 2010 1646 1647
46. R.D. Riley, W. Sauerbrei, and D.G. Altman Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond Br J Cancer 100 8 2009 1219 1229
47. D.E. Sigounas, A. Tatsioni, D.K. Christodoulou, E.V. Tsianos, and J.P. Ioannidis New Prognostic Markers for Outcome of Acute Pancreatitis: Overview of Reporting in 184 Studies Pancreas 40 4 2011 522 532
48. V. Gallo, A. Khan, C. Gonzales, D.H. Phillips, B. Schoket, E. Gyrffy, L. Anna, K. Kovács, P. Moller, S. Loft, S. Kyrtopoulos, G. Matullo, and P. Vineis Validation of biomarkers for the study of environmental carcinogens: a review Biomarkers 13 2008 505 534
49. P. Vineis, and V. Gallo Epidemiological concepts of validation of biomarkers for the identification/quantification of environmental carcinogenic exposures 2007 ECNIS Poland
50. P. Vineis, G. Matullo, and M. Berwick Molecular epidemiology W. Ahrens, I. Pigeot, Handbook of Epidemiology 2005 Springer Berlin & Heidelberg 1111 1138
51. P. Kristensen Bias from nondifferential but dependent misclassification of exposure and outcome Epidemiology 3 1992 210 215
52. P. Vineis Sources of variation in biomarkers IARC Sci Publ 142 1997 59 71
53. K. Vahakangas Ethical aspects of molecular epidemiology of cancer Carcinogenesis 25 2004 465 471